Chronic Mucocutaneous Candidiasis (CMC)

DBCOND0048700InfectionsSkin and Subcutaneous Tissue Diseases

Chronic Mucocutaneous Candidiasis (CMC) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Candidiasis, Chronic Mucocutaneous · Chronic Mucocutaneous Candidiasis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0003259SNOMED CT234568006MedDRA10009007UMLSC0006845

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Chronic Mucocutaneous Candidiasis (CMC) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In